Experimental Validation of the Long-term Accuracy of Blood Pressure Measurement Using a Smartwatch
NCT ID: NCT06098092
Last Updated: 2023-10-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2023-10-13
2024-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-invasive Blood Pressure Measurement Using Samsung Smartwatch
NCT05302193
Reliability of Measuring Blood Pressure With a Smartwatch
NCT05401435
Smartwatch ABPM vs. Conventional ABPM
NCT04553861
Validation of a Smartwatch for Blood Pressure Monitoring
NCT06627920
Validity Test of Wearable Continuous Blood Pressure Measuring System
NCT04261062
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Long-term Blood pressure and Heart rate monitoring with reference digital tonometer and smartwatch
Measurement of a non-invasive Blood pressure and Heart rate using a reference medical grade digital tonometer Omron and a smartwatch Samsung Galaxy Watch during 20-40 days every morning and evening.
Long-term non-invasive Blood pressure monitoring
All measurements during the experiment include only non-invasive Blood pressure and Heart rate measurements. Measurements will be taken using a smartwatch attached to the wrist and a digital tonometer with a cuff placed on the other arm. Paired readings will be compared.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Long-term non-invasive Blood pressure monitoring
All measurements during the experiment include only non-invasive Blood pressure and Heart rate measurements. Measurements will be taken using a smartwatch attached to the wrist and a digital tonometer with a cuff placed on the other arm. Paired readings will be compared.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* tattoos, birthmarks, injuries or diseases of the skin on the wrists of hands
* cardiac arrhythmias
* circulatory or peripheral varcular disease
* aortic valve disease
* myocardiopathy
* other cardiovascular diseases
* pregnancy
* kidney disease
* diabetes
* neurotic disorder
* haemostatic disorders
* use of blood-thinning drugs
22 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Czech Technical University in Prague
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jakub Rafl
Role: PRINCIPAL_INVESTIGATOR
Czech Technical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Czech Technical University in Prague
Kladno, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NVT_02_2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.